Market closed
Illumina/$ILMN
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Illumina
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Ticker
$ILMN
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
10,615
Website
Illumina Metrics
BasicAdvanced
$22B
Market cap
-
P/E ratio
-$9.98
EPS
1.13
Beta
-
Dividend rate
Price and volume
Market cap
$22B
Beta
1.13
52-week high
$156.66
52-week low
$100.09
Average daily volume
2.4M
Financial strength
Current ratio
2.434
Quick ratio
1.696
Long term debt to equity
122.4
Total debt to equity
125.835
Interest coverage (TTM)
3.63%
Management effectiveness
Return on assets (TTM)
2.62%
Return on equity (TTM)
-39.51%
Valuation
Price to revenue (TTM)
4.919
Price to book
10.11
Price to tangible book (TTM)
30.4
Price to free cash flow (TTM)
39.548
Growth
Revenue change (TTM)
-1.68%
Earnings per share change (TTM)
40.00%
3-year revenue growth (CAGR)
0.85%
3-year earnings per share growth (CAGR)
17.80%
What the Analysts think about Illumina
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Illumina stock.
Illumina Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Illumina Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Illumina News
AllArticlesVideos
Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
Seeking Alpha·3 weeks ago
Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript)
Seeking Alpha·1 month ago
Illumina: Q3 Confirms Improving Fundamentals
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Illumina stock?
Illumina (ILMN) has a market cap of $22B as of December 22, 2024.
What is the P/E ratio for Illumina stock?
The price to earnings (P/E) ratio for Illumina (ILMN) stock is 0 as of December 22, 2024.
Does Illumina stock pay dividends?
No, Illumina (ILMN) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Illumina dividend payment date?
Illumina (ILMN) stock does not pay dividends to its shareholders.
What is the beta indicator for Illumina?
Illumina (ILMN) has a beta rating of 1.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.